Latest Market Disclosure News

Mayne Pharma has addressed a sharp share price decline following the public release of an FDA Untitled Letter, confirming no undisclosed material information and reaffirming compliance with ASX rules.

Insignia Financial updates the market on its acquisition talks, revealing Bain Capital's withdrawal due to global market volatility while discussions with CC Capital continue without certainty.

Mayne Pharma Group has acknowledged a delayed filing of a director's interest notice due to administrative oversight and is taking steps to reinforce compliance with ASX disclosure rules.

Pure Foods Tasmania has executed key loan extensions with Commonwealth Bank and outlined a comprehensive turnaround strategy to address its financial challenges, despite ongoing material uncertainty over its going concern status.

Gladiator Resources has acknowledged a breach of its Securities Trading Policy following an on-market trade during a Black-Out Period, prompting a review of its compliance framework. The company reassures investors that subsequent trades were compliant and that governance standards remain a priority.

Viridis Mining and Minerals Limited has requested an immediate voluntary suspension of its shares pending a capital raising announcement, signaling a pivotal moment for the company.

Rewardle Holdings reports a strong December quarter with positive cash flow and a significant valuation uplift in its CloudHolter partnership, underpinning its multi-pronged growth strategy.

SIV Capital Limited reported a negative operating cash flow for Q2 FY25 and remains suspended from ASX trading due to compliance issues, while actively exploring acquisition opportunities.

Arafura Rare Earths Limited has acknowledged a breach of ASX Listing Rule 15.7 following premature media disclosure of a $200 million investment commitment from the National Reconstruction Fund Corporation. The company outlines corrective steps to prevent future compliance lapses.